326 related articles for article (PubMed ID: 26153793)
1. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
Bernardo B; Lu M; Bandyopadhyay G; Li P; Zhou Y; Huang J; Levin N; Tomas EM; Calle RA; Erion DM; Rolph TP; Brenner M; Talukdar S
Sci Rep; 2015 Jul; 5():11382. PubMed ID: 26153793
[TBL] [Abstract][Full Text] [Related]
2. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
3. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S
PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
6. FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1.
Kwon MM; O'Dwyer SM; Baker RK; Covey SD; Kieffer TJ
Cell Rep; 2015 Nov; 13(8):1521-7. PubMed ID: 26586424
[TBL] [Abstract][Full Text] [Related]
7. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
8. FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance.
Stöhr O; Tao R; Miao J; Copps KD; White MF
Cell Rep; 2021 Mar; 34(12):108893. PubMed ID: 33761350
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
10. FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues.
Schlein C; Talukdar S; Heine M; Fischer AW; Krott LM; Nilsson SK; Brenner MB; Heeren J; Scheja L
Cell Metab; 2016 Mar; 23(3):441-53. PubMed ID: 26853749
[TBL] [Abstract][Full Text] [Related]
11. Autocrine effects of transgenic resistin reduce palmitate and glucose oxidation in brown adipose tissue.
Pravenec M; Mlejnek P; Zídek V; Landa V; Šimáková M; Šilhavý J; Strnad H; Eigner S; Eigner Henke K; Škop V; Malínská H; Trnovská J; Kazdová L; Drahota Z; Mráček T; Houštěk J
Physiol Genomics; 2016 Jun; 48(6):420-7. PubMed ID: 27113533
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
[TBL] [Abstract][Full Text] [Related]
13. A
Ruan CC; Kong LR; Chen XH; Ma Y; Pan XX; Zhang ZB; Gao PJ
Cell Metab; 2018 Sep; 28(3):476-489.e5. PubMed ID: 30017353
[TBL] [Abstract][Full Text] [Related]
14. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
[TBL] [Abstract][Full Text] [Related]
15. Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21.
Kim EK; Lee SH; Jhun JY; Byun JK; Jeong JH; Lee SY; Kim JK; Choi JY; Cho ML
Mediators Inflamm; 2016; 2016():5813030. PubMed ID: 27057099
[TBL] [Abstract][Full Text] [Related]
16. Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster.
Lewis JE; Monnier C; Marshall H; Fowler M; Green R; Cooper S; Chiotellis A; Luckett J; Perkins AC; Coskun T; Adams AC; Samms RJ; Ebling FJP; Tsintzas K
Mol Metab; 2020 Jan; 31():45-54. PubMed ID: 31918921
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.
Camporez JP; Jornayvaz FR; Petersen MC; Pesta D; Guigni BA; Serr J; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Shulman GI
Endocrinology; 2013 Sep; 154(9):3099-109. PubMed ID: 23766126
[TBL] [Abstract][Full Text] [Related]
18. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.
Markan KR; Naber MC; Ameka MK; Anderegg MD; Mangelsdorf DJ; Kliewer SA; Mohammadi M; Potthoff MJ
Diabetes; 2014 Dec; 63(12):4057-63. PubMed ID: 25008183
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
20. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
